Accellacare of Wilmington — Wilmington, North Carolina

Accellacare of Wilmington is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Accellacare of Wilmington has participated in 7 clinical trials with 5 currently active.

Therapeutic areas: Respiratory Syncytial Virus Infections, Obesity, Heart Failure With Preserved Ejection Fraction.

Sponsors: Bavarian Nordic, Skye Bioscience, Inc., Amgen.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare of Wilmington?

Accellacare of Wilmington has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare of Wilmington conducted?

Accellacare of Wilmington has 7 clinical trials on record, with 5 currently active. Their work covers Respiratory Syncytial Virus Infections, Obesity, Heart Failure With Preserved Ejection Fraction.

Is Accellacare of Wilmington accredited by Crixeo Health?

Yes — Accellacare of Wilmington holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accellacare of Wilmington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.